Effects of enamel matrix derivate on bone-related mRNA expression in human periodontal ligament cells in vitro

Journal of Periodontology

Volumn 77, Issue 5, 2006, Pages 891-898

  Takayanagi, Kazuaki ^a   Osawa, Ginko ^a   Nakaya, Hiroshi ^a   Cochran, David L ^b   Kamoi, Kyuich ^a   Oates, Thomas W ^b  

^a NIPPON DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Core binding factor alpha 1; Cyclooxygenase 2; Osteoprotegerin; Periodontal ligament; Receptor activator of nuclear factor B ligand

Indexed keywords

CHLOROFORM; CYCLOOXYGENASE 2; ENAMEL MATRIX PROTEIN; ENAMEL PROTEIN; FRUCTOSE BISPHOSPHATE ALDOLASE; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PHENOL DERIVATIVE; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; CARRIER PROTEIN; CELL RECEPTOR; ENAMEL MATRIX PROTEINS; GLYCOPROTEIN; MEMBRANE PROTEIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, HUMAN; TNFRSF11B PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; BONE METABOLISM; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MINERALIZATION; MODULATION; PERIODONTAL LIGAMENT; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; STATISTICAL SIGNIFICANCE; ADOLESCENT; ADULT; CYTOLOGY; DRUG EFFECT; METABOLISM; METHODOLOGY;

ADOLESCENT; ADULT; CARRIER PROTEINS; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CYCLOOXYGENASE 2; DENTAL ENAMEL PROTEINS; GLYCOPROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; OSTEOPROTEGERIN; PERIODONTAL LIGAMENT; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33746025298     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2006.050244     Document Type: Article

References (59)

1. Schonfeld SE, Slavkin HC. Demonstration of enamel matrix proteins on root-analogue surfaces of rabbit permanent incisor teeth. Calcif Tissue Int 1977;24: 223-229.
2. 3H-proline uptake into the epithelial root sheath of Hertwig in vitro. J Craniofac Genet Dev Biol 1982;2:171-177.
3. Slavkin HC, Bringas P Jr., Bessem C, et al. Hertwig's epithelial root sheath differentiation and initial cementum and bone formation during long-term organ culture of mouse mandibular first molars using serumless, chemically-defined medium. J Periodontal Res 1989; 24:28-40.
4. Slavkin HC. Towards a cellular and molecular understanding of periodontics: Cementogenesis revisited. J Periodontol 1976;47:249-255.
5. Hammarström L. Enamel matrix, cementum development and regeneration. J Clin Periodontol 1997;24: 658-668.
6. Tonetti MS, Lang NP, Cortellini P, et al. Enamel matrix proteins in the regenerative therapy of deep intrabony defects. A multicentre randomized controlled clinical trial. J Clin Periodontol 2002;29:317-325.
7. Camargo PM, Lekovic V, Weinlaender M, Vasilic N, Kenny EB, Madzarevic M. The effectiveness of enamel matrix proteins used in combination with bovine porous bone mineral in the treatment of intrabony defects in humans. J Clin Periodontol 2001;28:1016-1022.
8. Bratthall G, Lindberg P, Havemose-Poulsen A, et al. Comparison of ready-to-use EMDOGEN-gel and EMDOGEN in patients with chronic adult periodontitis. A multicenter clinical study. J Clin Periodontol 2001; 28:923-929.
9. Heden G. A case report study of 72 consecutive Emdogain-treated intrabony periodontal defects: Clinical and radiographic findings after 1 year. Int J Periodontics Restorative Dent 2000;20:127-139.
10. Heijl L, Heden G, Svärdström G, Östgren A. Enamel matrix derivative (Emdogain) in the treatment of intrabony periodontal defects. J Clin Periodontol 1997; 24:705-714.
11. Silvestri M, Sartori S, Rasperini G, Ricci G, Rota C, Cattaneo V. Comparison of intrabony defects treated with enamel matrix derivative versus guided tissue regeneration with a nonresorborbable membrane. A multicenter controlled clinical trial. J Clin Periodontol 2003;30:386-393.
12. Hammarström L, Hejil L, Gestrelius S. Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol 1997;24:669-677.
13. Yukna RA, Mellonig JT. Histologic evaluation of periodontal healing in humans following regenerative therapy with enamel matrix derivative. A 10-case series. J Periodontol 2000;71:752-759.
14. Heijl L. Periodontal regeneration with enamel matrix derivative in one human experimental defect. A case report. J Clin Periodontol 1997;24:693-696.
15. Gestrelius S, Andersson C, Johansson A-C, et al. Formulation of enamel matrix derivative for surface coating. Kinetics and cell colonization. J Clin Periodontol 1997;24:678-684.
16. Gestrelius S, Andersson C, Lidstrom D, Hammarstrom L, Somerman M. In vitro studies on periodontal ligament cells and enamel matrix derivative. J Clin Periodontol 1997;24:685-692.
17. Haase HR, Bartold PM. Enamel matrix derivative induces matrix synthesis by cultured human periodontal flbroblast cells. J Periodontol 2001;72:341-348.
18. Hoang AM, Oates TW, Cochran DL. In vitro wound healing responses to enamel matrix derivative. J Periodontol 2000;71:1270-1277.
19. Schwartz Z, Carnes DL Jr., Pulliam R, et al. Porcine fetal enamel matrix derivative stimulates proliferation but not differentiation of pre-osteoblastic 2T9 cells, inhibits proliferation and stimulates differentiation of osteoblast-like MG63 cells, and increases proliferation and differentiation of normal human osteoblast NHOst cells. J Periodontol 2000;71:1287-1296.
20. Suda T, Takahashi N, Martin TJ. Modulation of osteoclast differentation. Endocr Rev 1992;13:66-80.
21. Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998; 95:3597-3602.
22. Simon AM, Manigrasso MB, O'Connor JP. Cyclooxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 2002;17:963-976.
23. Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O'Keef RJ. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 2002;109:1405-1415.
24. Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturation arrest of osteoblasts. Cell 1997; 89:755-764.
25. Otto F, Thornell AP, Crompton T, et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997;89:765-771.
26. Khosla S. Minireview: The OPG/RANK system. Endocrinology 2001;142:5050-5055.
27. Yoshida K, Oida H, Kobayashi T, et al. Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc Natl Acad Sci USA 2002;99:4580-4585.
28. Nukaga J, Kobayashi M, Shinki T, et al. Regulatory effects of interleukin-1 beta and prostaglandin E2 on expression of receptor activator of nuclear factor-kappaB ligand in human periodontal ligament cells. J Periodontol 2004;75:249-259.
29. Wada N, Maeda H, Yoshimine Y, Akamine A. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha. Bone 2004;35:629-635.
30. Fukushima H, Kajiya H, Takada K, Okamoto F, Okabe K. Expression and role of RANKL in periodontal ligament cells during physiological root-resorption in human deciduous teeth. Eur J Oral Sci 2003; 111: 346-352.
31. Tsuji K, Uno K, Zhang GX, Tamura M. Periodontal ligament cells under intermittent tensile stress regulate mRNA expression of osteoprotegerin and tissue inhibitor of matrix metalloprotease-1 and -2. J Bone Miner Metab 2004;22:94-103.
32. Kaku M, Uoshima K, Yamashita Y, Miura H. Investigation of periodontal ligament reaction upon excessive occlusal load - Osteopontin induction among periodontal ligament cells. J Periodontal Res 2005; 40:59-66.
33. Nakaya H, Osawa G, Iwasaki N, Cochran DL, Kamoi K, Oates TW. Effects of bisphosphonate on matrix metalloproteinase enzymes in human periodontal ligament cells. J Periodontol 2000;71:1158-1166.
34. Nakaya H, Oates TW, Hoang AM, Kamoi K, Cochran DL. Effects of interleukin 1B on matrix metalloproteinase-3 levels in human periodontal ligament cells. J Periodontol 1997;68:517-523.
35. Kanzaki H, Chiba M, Shimizu Y, Mitani H. Dual regulation of osteoclast differentiation by periodontal ligament cells through RANKL stimulation and OPG inhibition. J Dent Res 2001;80:887-891.
36. Sasaki-Iwaoka H, Maruyama K, Endoh H, Komori T, Kato S, Kawashima H. A trans-acting enhancer modulates estrogen-mediated transcription of reporter genes in osteoblasts. J Bone Miner Res 1999;14: 248-255.
37. Chen D, Magnuson V, Hill S, Arnaud C, Steffensen B, Klebe RJ. Regulation of integrin gene expression by substrate adherence. J Biol Chem 1992;267:23502-23506.
38. 2 synthesis. J Bone Miner Res 2002;17:210-220.
39. Takai H, Kanematsu M, Yano K, et al. Transforming growth factor-β stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. J Biol Chem 1998;273:27091-27096.
40. Quinn JM, Itoh K, Udagawa N, et al. Transforming growth factor β affects osteoclast differentiation via direct and indirect actions. J Bone Miner Res 2001; 16:1787-1794.
41. WAF1/cip1 and prevents its inhibition of human oral epithelial cell proliferation. J Periodontal Res 2002;37:255-262.
42. Lyngstadaas SP, Lundberg E, Ekdahl H, Andersson C, Gestrelius S. Autocrine growth factors in human periodontal ligament cells cultured on enamel matrix derivative. J Clin Periodontol 2001;28: 181-188.
43. Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 1997;89:309-319.
44. Yasuda H, Shima N, Nakagawa N, et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 1998;139:1329-1337.
45. Tsuda E, Goto M, Mochizuki S, et al. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 1997;234:137-142.
46. Wada N, Maeda H, Tanabe K, et al. Periodontal ligament cells secrete the factor that inhibits osteoclastic differentiation and function: The factor is osteoprotegerin/osteoclastogenesis inhibitory factor. J Periodontal Res 2001;36:56-63.
47. Murakami T, Yamamoto M, Yamamoto M, et al. Transforming growth factor-β1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. Biochem Biophys Res Commun 1998; 252:747-752.
48. Kato C, Kojima T, Komaki M, et al. S100A4 inhibition by RNAi up-regulates osteoblast related genes in periodontal ligament cells. Biochem Biophys Res Commun 2005;326:147-153.
49. He J, Jiang J, Safavi KE, Spangberg LS, Zhu Q. Emdogain promotes osteoblast proliferation and differentiation and stimulates osteoprotegerin expression. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;97:239-245.
50. Moore KD, Goss K, Anglen JO. Indomethacin versus radiation therapy for prophylaxis against heterotopic ossification in acetabular fractures: A randomised, prospective study. J Bone Joint Surg Br 1998;80: 259-263.
51. Saito Y, Yoshizawa T, Takizawa F, et al. A cell line with characteristics of the periodontal ligament fibroblasts is negatively regulated for mineralization and Runx2/Cbfa1/Osf2 activity, part of which can be overcome by bone morphogenetic protein-2. J Cell Sci 2002;115: 4191-4200.
52. Fransen M, Neal B. Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty. Cochrane Database Syst Rev 2004; 3:CD001160.
53. Lekic P, McCulloch CAG. Periodontal ligament cell populations: The central role of fibroblasts in creating a unique tissue. Anat Rec 1996;245:327-341.
54. Kawase T, Sato S, Miake K, Saito S. Alkaline phosphatase of human periodontal ligament fibroblast-like cells. Adv Dent Res 1988;2:234-239.
55. Somerman MJ, Young MF, Foster RA, Moehring JM, Imm GM, Sauk JJ. Characteristics of human periodontal ligament cells in vitro. Arch Oral Biol 1990; 35:241-247.
56. Nohutcu RM, McCauley LK, Shigeyama Y, Somerman MJ. Expression of mineral-associated proteins by periodontal ligament cells: In vitro vs. ex vivo. J Periodontal Res 1996;31:369-372.
57. Nojima N, Kobayashi M, Shionome M, Takahashi N, Suda T, Hasegawa K. Fibroblastic cells derived from bovine periodontal ligaments have the phenotypes of osteoblasts. J Periodontal Res 1990;25:179-185.
58. Keila S, Nemcovsky CE, Moses O, Artzi Z, Weinreb M. In vitro effects of enamel matrix proteins on rat bone marrow cells and gingival fibroblasts. J Dent Res 2004;83:134-138.
59. Shui C, Spelsberg TC, Riggs BL, Khosla S. Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells. J Bone Miner Res 2003;18:213-221.